Abstract PR012: Novel strategy for RAS-pathway targeting: Initial results from a phase 1b/2 clinical trial of the oral HDAC inhibitor bocodepsin (OKI-179) combined with binimetinib... von Amaria, Rodabe N, Duvivier, Herbert, Tsai, Katy, Galamaga, Robert, Momtaz, Parisa, Pisick, Evan, Langr, Natalie, Dave, Harish, Walker, Duncan, Diamond, Jennifer, Litwiler, Kevin, Sullivan, Ryan

Volltext